Articles From: AmeriServ Financial, Inc. Announces Expected Third Quarter Goodwill Impairment Charge And Profitability Improvement Initiatives to Amgen Issues Voluntary Recall of Aranesp® (darbepoetin alfa) (500 mcg) Prefilled Syringes in Several Countries Outside of the United States Due to the Presence of Visible Particulates


JOHNSTOWN, Pa.
Sign-up for AmeriServ Financial, Inc. Declares Quarterly Common Stock Cash Dividend investment picks
AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the 2014 Third Fiscal Quarter on Thursday, July 24, 2014 prior to the opening of trading on the New York Stock Exchange.
Sign-up for AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2014 Earnings Release investment picks
MADRID (MarketWatch) -- AmerisourceBergen Corp.
Sign-up for AmerisourceBergen beats forecasts, lifted by new business investment picks
The Board of Directors of AmerisourceBergen Corporation (NYSE:ABC) today declared a quarterly dividend of $0.235 per common share, payable September 2, 2014, to stockholders of record at the close of business on August 18, 2014.
Sign-up for AmerisourceBergen Declares Quarterly Dividend investment picks
AmerisourceBergen Corporation (NYSE:ABC) today reported that in its fiscal year 2014 third quarter ended June 30, 2014, adjusted diluted earnings per share from continuing operations increased 29.5% percent to $1.01. Revenue increased 38.5 percent to $30.3 billion in the quarter.
Sign-up for AmerisourceBergen Reports Third Quarter Fiscal Year 2014 Results investment picks
2014/9/17
KANSAS CITY, Mo., Sept.
Sign-up for Ameristar Casino Hotel Kansas City Announces New Vice President & General Manager and Assistant General Manager investment picks
2014/9/17
BLACK HAWK, Colo., Sept.
Sign-up for Ameristar Casino Resort Spa Black Hawk Announces New Vice President & General Manager and Assistant General Manager investment picks
Amerita, Inc., a wholly owned subsidiary of PharMerica Corporation (NYSE:PMC), announced today that it has acquired Altius Healthcare.
Sign-up for Amerita, a Subsidiary of PharMerica, Expands into Arizona Through the Acquisition of Altius Healthcare investment picks
Airborne Maintenance & Engineering Services (AMES), a subsidiary of Air Transport Services Group (Nasdaq:ATSG), has been granted approval by the Federal Aviation Administration (FAA) to perform heavy and line maintenance services on Airbus A318, A319, A320, and A321 aircraft.
Sign-up for AMES Adds Airbus Models to Maintenance Capabilities investment picks
Earnings to be Released before the Market Opens on Tuesday, August 5, 2014 Webcast Scheduled for 8:30 AM ET on August 5, 2014 BERWYN, Pa.
Sign-up for AMETEK Announces Second Quarter 2014 Earnings Release And Webcasted Investor Conference Call investment picks
-- AMPTEK, Inc. Broadens AMETEK's Materials Analysis Capabilities -- -- Luphos GmbH Adds Unique Technology to AMETEK's Metrology Platform --
Sign-up for AMETEK Announces Two Acquisitions investment picks
BERWYN, Pa.
Sign-up for AMETEK Declares Quarterly Dividend Of Nine Cents Per Share investment picks
BERWYN, Pa.
Sign-up for AMETEK Names Robert J. Amodei Vice President, Audit Services investment picks
Presentation to be Webcast at 2:45 PM ET on Tuesday, September 23 BERWYN, Pa.
Sign-up for AMETEK to Present at the Citi 2014 Industrials Conference investment picks
Affiliated Managers Group, Inc. (NYSE: AMG) today reported its financial and operating results for the second quarter and six months ended June 30, 2014.
Sign-up for AMG Reports Financial and Operating Results for the Second Quarter and First Half of 2014 investment picks
Affiliated Managers Group, Inc. (NYSE: AMG) will report financial and operating results for the second quarter ended June 30, 2014 on Tuesday, July 29, 2014.
Sign-up for AMG to Announce Second Quarter Results on July 29, 2014 investment picks
THOUSAND OAKS, Calif.
Sign-up for Amgen Announces 2014 Third Quarter Dividend investment picks
Data Include Eight Year Analyses of Bone Mineral Density Results for Prolia® (Denosumab) and Further Evidence for Significant Bone-Building With Romosozumab THOUSAND OAKS, Calif.
Sign-up for Amgen Announces 23 Abstracts To Be Presented At The American Society for Bone and Mineral Research 2014 Annual Meeting investment picks
Kyprolis Helped Patients Live 8.7 Months Longer Without Their Disease Worsening Results to Form Basis of Regulatory Filings Beginning in 1H 2015 THOUSAND OAKS, Calif.
Sign-up for Amgen Announces Phase 3 ASPIRE Trial Of Kyprolis® In Patients With Relapsed Multiple Myeloma Met Primary Endpoint investment picks
Analysis Shows Study Met Primary and All Secondary Endpoints AMG 416 is a Novel Calcimimetic Administered Intravenously THOUSAND OAKS, Calif.
Sign-up for Amgen Announces Positive Phase 3 Results for AMG 416 for the Treatment of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease Receiving Hemodialysis investment picks
Study Meets Co-Primary Endpoints of LDL Cholesterol Reduction THOUSAND OAKS, Calif.
Sign-up for Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial Of Evolocumab In Combination With Statins In Japanese Patients With High Cardiovascular Risk And High Cholesterol investment picks
Second Phase 3 Registrational Study Meets Primary and All Secondary Endpoints AMG 416 is a Novel Calcimimetic Administered Intravenously THOUSAND OAKS, Calif.
Sign-up for Amgen Announces Positive Top-Line Results From Second Phase 3 Study Of AMG 416 For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease Receiving Hemodialysis investment picks
Data Presented at the American Society of Bone and Mineral Research 2014 Annual Meeting THOUSAND OAKS, Calif.
Sign-up for Amgen Announces Results From Several New Exploratory Analyses Evaluating Long-Term Impact Of Treatment With Prolia® (Denosumab) In Postmenopausal Women With Osteoporosis investment picks
THOUSAND OAKS, Calif.
Sign-up for Amgen Announces Webcast of 2014 Second Quarter Financial Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: AmeriServ Financial, Inc. Announces Expected Third Quarter Goodwill Impairment Charge And Profitability Improvement Initiatives to Amgen Issues Voluntary Recall of Aranesp® (darbepoetin alfa) (500 mcg) Prefilled Syringes in Several Countries Outside of the United States Due to the Presence of Visible Particulates
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices